A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Multi-Link Vision stent vs. first-generation drug-eluting stents: systematic review and meta-analysis
QJM: Quarterly journal of medicine
TVR. Risk of ST was 0.5%. Compared to first generation of DES in RCTs, at a mean follow-up of 10.5 months, MLV achieved similar results in terms of MAE, death and MI. On the other hand, MLV was associated with a double risk of TVR [OR 2.01 (1.34-3.01), P < 0.001, number needed to treat 18 (13-40)]. Overall, in stent late loss with MLV was 0.81 mm (AE0.51), while the in segment late loss was 0.61 mm (AE0.5). Risk of stent thrombosis was equivalent. Of note, performance of MLV in terms of safety,doi:10.1093/qjmed/hcr138 pmid:21896624 fatcat:sy3wwn5trnexdcf7wpjo7heqjm